Joy Melhado
Psychiatric/Mental Health · Carlsbad, CANPI 1225793003
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 30.6% of the total. 2025 is the largest year on record at $1,219, more than ten times the $42 reported in 2021.
Across 194 payments — averaging $19.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Lundbeck LLC$865
- Otsuka America Pharmaceutical, Inc.$590
- Takeda Pharmaceuticals U.S.A., Inc.$449
- AbbVie$299
- Axsome Therapeutics, Inc.$150
- plus $333 from 7 others
What the payments were for
- Food & beverage$3,81098%
- Education$592%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 46 | $1,183 |
| Lundbeck LLC | 67 | $865 |
| Otsuka America Pharmaceutical, Inc. | 30 | $590 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $449 |
| AbbVie | 11 | $299 |
| Axsome Therapeutics, Inc. | 3 | $150 |
| Johnson & Johnson | 5 | $119 |
| Alkermes, Inc. | 3 | $57 |
| Idorsia Pharmaceuticals US Inc | 3 | $49 |
| Sunovion Pharmaceuticals Inc. | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,869 in reported general payments places this provider in the 85th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $600 |
| Sertraline Hcl | 11 | $36 |
| Escitalopram Oxalate | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Carlsbad
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
- Jonathan LlamasPasadena$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.